Forbes May 5, 2021
Information from the IPO dossier of Rockley Photonics, a British startup led by Andrew Rickman that develops health parameter sensors, provides insight into its relationship with Apple — its main customer — and leads The Telegraph to speculate that the next Apple Watches could incorporate additional sensors to measure glucose, blood alcohol levels and blood pressure.
These sensors, coupled with existing heart rate monitoring, electrocardiograms, algorithms for determining certain arrhythmias and calculation of blood oxygen concentration, would turn the Apple Watch into a “doctor on your wrist”, enabling comprehensive monitoring of critical health parameters for many patients. This would make the Apple Watch an irreplaceable value proposition for millions of people with heart conditions, diabetes, respiratory diseases or, in general, for virtually anyone interested...
Today's Sponsors
Today's Sponsor